A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
Titel:
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
Auteur:
Ricart, Alejandro D. Ashton, Edward A. Cooney, Matthew M. Sarantopoulos, John Brell, Joanna M. Feldman, Maria A. Ruby, Kale E. Matsuda, Kazuko Munsey, Mark S. Medina, Gerardo Zambito, Angela Tolcher, Anthony W. Remick, Scot C.